Skip to main content
Screener/Healthcare/Biotechnology

RAPP — Rapport Therapeutics, Inc. Common Stock

NASDAQ
$36.16+1.51 (+4.36%)
Small CapUnder $50HealthcareHigh Beta
$7.73
$42.27
$34.46
$36.46
EPS (TTM)$-2.86
P/E Ratio—
Dividend Yield—
Market Cap$1.18B
Volume251K
Prev Close$34.65
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$33.8M$-0.72——
Q3 '25$0-$26.9M$-0.71——
Q2 '25$0-$26.7M$-0.75——
Q1 '25$0-$24.1M$-0.68——
Q4 '24$0-$20.0M$-0.12——
Q3 '24$0-$17.5M$-0.50——
Q2 '24$0-$18.1M$-1.70——
Q1 '24$0-$22.7M$-4.72——
Get Your Daily Market Recap
RAPP Stock Price, Chart & Analysis | TickFlow